STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
Reported by STAT News · all stories from statnews.com
Editorial digest
Developments include direct-to-consumer availability of AI tools for breast cancer risk assessment. The piece also covers regulatory questions surrounding Utah's AI sandbox and the topic of AI-induced psychosis.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/30/2026
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Federal health agencies are working quickly to prevent oversight bottlenecks as states prepare clinical artificial intelligence trials.
- Trusted health newsroom10/5/2026
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
Utah continues expanding health AI pilot programs for prescriptions and women's health.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
- Trusted health newsroom10/15/2026
Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening
An opinion piece describes difficulties in opting out of health data sharing through MyChart.
- Trusted health newsroom9/15/2026
STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal
Medicare's AI prior authorization program faced issues and was launched too quickly, according to new details.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.